Table 1. In vitro studies employing anti-CD69 monoclonal antibodies in different human cells.

Abbreviations included in Table 1. Peripheral blood lymphocytes, PBLs; peripheral blood mononuclear cells, PBMCs; Natural killer cells, NK; Phorbol 12-myristate 13-acetate, PMA; Phytohemagglutinin, PHA; Protein kinase C, PKC; Interferon-γ, IFN-γ; Nuclear factor of activated T cells 1, NFAT; Thromboxane B2, TXB2; Thromboxane A2, TXA2; Prostaglandin E2, PGE2; Activator protein 1, AP-1; Phospholipase A2, PLA₂; Cyclosporine A, CsA; Lipopolysaccharide, LPS; Granulocyte macrophage colony-stimulating factor ,GM-CSF; 6-keto-prostaglandin F1α, 6-ketoPGF1α; Leukotriene B4, LTB4; Nitric oxide, NO; Transforming growth factor-beta 1,TGF-β1; Diacylglycerol, DAG; intercellular adhesion molecule-1, ICAM-1; tumor necrosis factor, TNF-α; extracellular signal-regulated kinase, ERK; Tyrosine-protein kinase, Syk; Proto-oncogene tyrosine-protein kinase, Src; Phospholipase Cγ2, PLCγ2; Vav Guanine Nucleotide Exchange Factor 1, Vav1